Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

James Miller

Concepts (325)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Lung Neoplasms
44
2020
2664
2.420
 Why?
Smoking
20
2019
1468
1.190
 Why?
Bronchi
13
2018
263
1.110
 Why?
Carcinoma in Situ
5
2019
44
1.030
 Why?
Carcinoma, Squamous Cell
10
2018
644
0.720
 Why?
Carcinogens
4
2012
123
0.710
 Why?
Chemoprevention
3
2019
92
0.670
 Why?
Vascular Endothelial Growth Factor Receptor-2
2
2012
86
0.670
 Why?
Lung
16
2020
4103
0.560
 Why?
Carcinoma, Small Cell
7
2008
172
0.460
 Why?
Bronchoscopy
9
2019
227
0.460
 Why?
Urethane
3
2012
43
0.450
 Why?
Sputum
8
2019
308
0.430
 Why?
Bronchopulmonary Dysplasia
2
2019
411
0.430
 Why?
Pulmonary Alveoli
4
2012
383
0.430
 Why?
Iloprost
2
2012
45
0.430
 Why?
Hyperplasia
7
2011
177
0.420
 Why?
Precancerous Conditions
7
2020
166
0.410
 Why?
Neprilysin
3
1998
47
0.390
 Why?
Quinazolines
2
2012
266
0.360
 Why?
Biopsy
11
2019
1081
0.360
 Why?
Piperidines
2
2012
221
0.360
 Why?
Biomarkers, Tumor
7
2015
1321
0.360
 Why?
Antineoplastic Agents
4
2013
2207
0.350
 Why?
DNA Copy Number Variations
1
2011
184
0.320
 Why?
Genetic Markers
1
2011
334
0.320
 Why?
Bombesin
5
1998
10
0.320
 Why?
Amidohydrolases
3
1998
32
0.310
 Why?
Neurosecretory Systems
4
2004
31
0.300
 Why?
Isotretinoin
1
2009
26
0.300
 Why?
Ki-67 Antigen
3
2015
117
0.290
 Why?
Vasodilator Agents
1
2011
330
0.290
 Why?
Tocopherols
1
2009
31
0.290
 Why?
Carcinoma, Non-Small-Cell Lung
7
2013
1188
0.290
 Why?
ErbB Receptors
1
2012
635
0.290
 Why?
Neovascularization, Pathologic
6
2015
284
0.270
 Why?
Pulmonary Disease, Chronic Obstructive
4
2018
919
0.270
 Why?
Membrane Proteins
2
2008
1164
0.270
 Why?
Mass Screening
3
2008
1358
0.260
 Why?
Respiratory Mucosa
2
2008
322
0.240
 Why?
Adenocarcinoma
6
2012
923
0.230
 Why?
Hypoxia
1
2012
1199
0.210
 Why?
Chromosomes, Human, Pair 3
4
2000
43
0.210
 Why?
Carcinoma, Bronchogenic
2
2002
20
0.200
 Why?
Chromosome Aberrations
4
2013
164
0.200
 Why?
Tomography, Spiral Computed
1
2002
30
0.190
 Why?
Middle Aged
28
2019
36176
0.180
 Why?
Aged
25
2019
26125
0.180
 Why?
Smokers
2
2019
137
0.170
 Why?
Humans
53
2020
145491
0.170
 Why?
Sensitivity and Specificity
10
2010
2002
0.170
 Why?
Placebos
2
2019
193
0.170
 Why?
Lung Diseases
5
2015
783
0.170
 Why?
Double-Blind Method
2
2019
2060
0.160
 Why?
Female
33
2019
78763
0.160
 Why?
Small Cell Lung Carcinoma
2
2012
121
0.160
 Why?
Tomography, X-Ray Computed
2
2020
2772
0.150
 Why?
Tumor Cells, Cultured
6
1998
883
0.150
 Why?
Neuropeptides
4
1998
75
0.150
 Why?
Radiographic Image Interpretation, Computer-Assisted
1
2020
127
0.150
 Why?
Male
30
2019
72817
0.140
 Why?
Remission Induction
1
2019
309
0.140
 Why?
In Situ Hybridization, Fluorescence
6
2010
324
0.140
 Why?
Blotting, Western
4
2012
1162
0.140
 Why?
Peptides
3
1996
993
0.130
 Why?
Genes, p53
1
1997
67
0.130
 Why?
Lung Diseases, Obstructive
1
1997
43
0.130
 Why?
Immunohistochemistry
8
2015
1710
0.130
 Why?
Point Mutation
1
1997
242
0.120
 Why?
Antibodies, Monoclonal
3
2010
1511
0.120
 Why?
Radiation Injuries, Experimental
1
1996
20
0.120
 Why?
Proteomics
2
2015
1191
0.120
 Why?
Bradykinin
1
1996
49
0.120
 Why?
Endopeptidases
1
1996
79
0.120
 Why?
Chromosomal Instability
2
2013
21
0.110
 Why?
Smoking Cessation
1
2019
437
0.110
 Why?
Multiple Pulmonary Nodules
1
2015
23
0.110
 Why?
Hyperoxia
1
1996
96
0.110
 Why?
Mice
10
2012
18338
0.110
 Why?
Animals
13
2013
38141
0.110
 Why?
Gene Expression
3
1998
1478
0.110
 Why?
Methylcholanthrene
2
2012
21
0.100
 Why?
Antigens
1
1996
349
0.100
 Why?
Mice, Transgenic
5
2009
2189
0.100
 Why?
Butylated Hydroxytoluene
2
2012
37
0.100
 Why?
Microarray Analysis
1
2013
116
0.100
 Why?
Risk Factors
5
2019
10874
0.100
 Why?
Stem Cells
1
2018
626
0.100
 Why?
Mutation
4
2000
4093
0.100
 Why?
Epithelium
4
2018
310
0.100
 Why?
Algorithms
3
2020
1855
0.100
 Why?
Intramolecular Oxidoreductases
2
2004
65
0.100
 Why?
Aged, 80 and over
8
2015
8326
0.090
 Why?
Risk
5
2012
917
0.090
 Why?
Carcinoma, Large Cell
1
2012
17
0.090
 Why?
Epithelial Cells
3
2007
1112
0.090
 Why?
Biological Products
1
1996
258
0.090
 Why?
Cytochrome P-450 Enzyme System
2
2004
161
0.090
 Why?
Receptors, Bombesin
1
2012
5
0.090
 Why?
Bronchoalveolar Lavage Fluid
3
2002
636
0.090
 Why?
Cell Division
4
2000
753
0.090
 Why?
Immunoenzyme Techniques
1
2012
199
0.090
 Why?
Volatile Organic Compounds
1
2012
60
0.090
 Why?
Case-Control Studies
8
2012
3619
0.090
 Why?
Dose-Response Relationship, Drug
2
2010
2030
0.080
 Why?
Chromosomes, Human, Pair 15
1
2011
50
0.080
 Why?
Sleep Apnea Syndromes
1
2012
98
0.080
 Why?
Eosinophilic Granuloma
1
1990
3
0.080
 Why?
Proto-Oncogene Proteins c-myc
1
2012
167
0.080
 Why?
Epithelial-Mesenchymal Transition
1
2012
211
0.080
 Why?
Veterans
1
2002
1626
0.080
 Why?
Antioxidants
2
2012
549
0.080
 Why?
Cell Line
5
2013
2823
0.080
 Why?
Plants, Toxic
1
1989
18
0.080
 Why?
Proteins
1
1996
1020
0.080
 Why?
Somatomedins
1
2009
28
0.080
 Why?
Genome-Wide Association Study
2
2013
1378
0.080
 Why?
Calcium
1
1996
1190
0.080
 Why?
Cell Proliferation
2
2018
2499
0.070
 Why?
Predictive Value of Tests
4
2009
2129
0.070
 Why?
Disease Progression
5
2018
2862
0.070
 Why?
Bronchial Neoplasms
1
2009
15
0.070
 Why?
Intracellular Signaling Peptides and Proteins
2
2011
456
0.070
 Why?
Chromosome Deletion
1
1989
126
0.070
 Why?
Neoplasms, Glandular and Epithelial
1
2009
52
0.070
 Why?
Airway Obstruction
3
2009
154
0.070
 Why?
Respiratory System
1
1989
151
0.070
 Why?
Adult
16
2018
40707
0.070
 Why?
GPI-Linked Proteins
1
2008
81
0.070
 Why?
Neoplasm Invasiveness
4
2015
505
0.070
 Why?
Polymorphism, Genetic
1
2011
616
0.070
 Why?
Fluorescence
3
2009
154
0.070
 Why?
Alkaline Phosphatase
1
2008
144
0.070
 Why?
Spectral Karyotyping
1
2007
5
0.070
 Why?
Isoenzymes
1
2008
297
0.070
 Why?
Cell Transformation, Neoplastic
1
2009
337
0.060
 Why?
Molecular Targeted Therapy
1
2010
439
0.060
 Why?
Molecular Sequence Data
5
1998
2910
0.060
 Why?
Proto-Oncogene Proteins p21(ras)
1
2008
254
0.060
 Why?
Pulmonary Surfactants
2
1999
104
0.060
 Why?
Inflammation
1
2018
2883
0.060
 Why?
Fibroblasts
3
1998
1023
0.060
 Why?
Exons
2
1998
363
0.060
 Why?
MicroRNAs
1
2012
689
0.060
 Why?
Polymorphism, Single Nucleotide
1
2013
2146
0.060
 Why?
Follow-Up Studies
2
2015
5426
0.060
 Why?
Enzyme-Linked Immunosorbent Assay
3
2005
839
0.060
 Why?
Early Detection of Cancer
1
2010
482
0.060
 Why?
ROC Curve
3
2015
619
0.060
 Why?
Adaptor Proteins, Signal Transducing
1
2008
426
0.060
 Why?
Recombinant Proteins
3
1998
1367
0.060
 Why?
Biomarkers
3
2010
4283
0.050
 Why?
Polymerase Chain Reaction
3
1998
1049
0.050
 Why?
RNA, Messenger
3
1998
2820
0.050
 Why?
Growth Hormone-Releasing Hormone
1
2004
19
0.050
 Why?
Acromegaly
1
2004
17
0.050
 Why?
Cytokines
1
2012
2054
0.050
 Why?
Protein Kinase Inhibitors
1
2010
980
0.050
 Why?
Adrenocorticotropic Hormone
1
2004
147
0.050
 Why?
Rats
4
2004
5581
0.050
 Why?
Base Sequence
3
1998
2180
0.050
 Why?
Smoke
1
2004
148
0.050
 Why?
Solitary Pulmonary Nodule
1
2002
25
0.050
 Why?
Metaplasia
2
2018
57
0.050
 Why?
Neoplasm Recurrence, Local
1
2009
1150
0.050
 Why?
Vascular Endothelial Growth Factor A
1
2005
550
0.050
 Why?
Cross-Sectional Studies
2
2018
5891
0.040
 Why?
Sex Factors
1
2007
2110
0.040
 Why?
Hospitals, Veterans
1
2002
259
0.040
 Why?
Pulmonary Fibrosis
2
1998
393
0.040
 Why?
Radiation Dosage
1
2002
196
0.040
 Why?
Reproducibility of Results
1
2008
3424
0.040
 Why?
Gene Expression Regulation
1
1989
2594
0.040
 Why?
Amino Acid Sequence
3
1994
2137
0.040
 Why?
Cohort Studies
4
2015
5992
0.040
 Why?
Gastrin-Releasing Peptide
2
1996
6
0.040
 Why?
Autocrine Communication
1
1998
38
0.040
 Why?
Desmoglein 3
1
2018
14
0.040
 Why?
gamma Catenin
1
2018
13
0.040
 Why?
Loss of Heterozygosity
2
2013
52
0.030
 Why?
DNA Primers
2
1998
507
0.030
 Why?
Light
1
2001
406
0.030
 Why?
Up-Regulation
2
2005
848
0.030
 Why?
Signal Transduction
3
1998
5202
0.030
 Why?
Bronchial Diseases
1
2018
38
0.030
 Why?
Paracrine Communication
1
1998
67
0.030
 Why?
Neoplasm Transplantation
1
1998
246
0.030
 Why?
Feasibility Studies
1
2002
1119
0.030
 Why?
Telangiectasia, Hereditary Hemorrhagic
1
1998
14
0.030
 Why?
Vascular Cell Adhesion Molecule-1
1
1998
41
0.030
 Why?
Gene Expression Profiling
1
2005
1769
0.030
 Why?
Time
1
2018
86
0.030
 Why?
Polymorphism, Single-Stranded Conformational
1
1997
26
0.030
 Why?
Cell Cycle Checkpoints
1
2018
98
0.030
 Why?
Genes, Tumor Suppressor
1
1998
85
0.030
 Why?
Alveolitis, Extrinsic Allergic
1
1998
93
0.030
 Why?
Polymorphism, Restriction Fragment Length
1
1997
63
0.030
 Why?
Likelihood Functions
1
1998
140
0.030
 Why?
DNA, Complementary
1
1998
273
0.030
 Why?
Gene Expression Regulation, Enzymologic
1
1998
268
0.030
 Why?
Codon
1
1997
93
0.030
 Why?
Neoplasm Staging
2
2012
1468
0.030
 Why?
Introns
1
1998
256
0.030
 Why?
Mice, Nude
1
1998
678
0.030
 Why?
Membrane Glycoproteins
1
1999
496
0.030
 Why?
United States
2
2011
16115
0.030
 Why?
Enzyme Activation
1
1998
762
0.030
 Why?
Immunoassay
2
1998
108
0.030
 Why?
Incidence
3
2010
2915
0.030
 Why?
Treatment Outcome
1
2011
11831
0.030
 Why?
RNA, Neoplasm
1
1996
83
0.030
 Why?
Glycopeptides
1
1996
44
0.030
 Why?
Image Processing, Computer-Assisted
1
2020
780
0.030
 Why?
Mesothelioma
1
1996
51
0.030
 Why?
Proto-Oncogene Proteins
1
2018
620
0.030
 Why?
Sequence Analysis, DNA
1
1998
831
0.030
 Why?
Antigens, CD
2
1998
557
0.030
 Why?
Receptors, Peptide
1
1994
18
0.030
 Why?
Cell Cycle Proteins
1
2018
631
0.030
 Why?
Machine Learning
1
2020
590
0.030
 Why?
Databases, Factual
1
2020
1500
0.030
 Why?
Rh-Hr Blood-Group System
1
1994
15
0.030
 Why?
Myelin Sheath
1
1996
169
0.030
 Why?
Erythrocyte Membrane
1
1994
54
0.030
 Why?
Blotting, Southern
1
1993
84
0.020
 Why?
Blotting, Northern
1
1993
203
0.020
 Why?
Neoplasm Metastasis
1
1996
691
0.020
 Why?
Prospective Studies
3
2012
8039
0.020
 Why?
Cells, Cultured
2
2007
4127
0.020
 Why?
DNA, Neoplasm
1
1993
158
0.020
 Why?
Solid Phase Microextraction
1
2012
7
0.020
 Why?
Endoscopy
1
2015
317
0.020
 Why?
Dinoprostone
2
2004
180
0.020
 Why?
Fluorescent Antibody Technique
1
1993
364
0.020
 Why?
Cloning, Molecular
1
1993
535
0.020
 Why?
Gas Chromatography-Mass Spectrometry
1
2012
127
0.020
 Why?
Breath Tests
1
2012
77
0.020
 Why?
Enzyme Inhibitors
1
1996
821
0.020
 Why?
Colorado
1
2002
4572
0.020
 Why?
Gene Expression Regulation, Neoplastic
1
2018
1439
0.020
 Why?
Liver Neoplasms
1
1998
779
0.020
 Why?
Iceland
1
2011
11
0.020
 Why?
Tumor Suppressor p53-Binding Protein 1
1
2011
14
0.020
 Why?
Spain
1
2011
51
0.020
 Why?
Netherlands
1
2011
82
0.020
 Why?
Respiratory Tract Diseases
1
1992
176
0.020
 Why?
Cattle
1
1993
977
0.020
 Why?
Rats, Sprague-Dawley
1
1996
2526
0.020
 Why?
Administration, Oral
1
2012
863
0.020
 Why?
Meta-Analysis as Topic
1
2011
171
0.020
 Why?
Severity of Illness Index
1
2018
2945
0.020
 Why?
Carrier Proteins
1
1994
733
0.020
 Why?
Receptor, IGF Type 1
1
2009
63
0.020
 Why?
Flow Cytometry
1
1993
1156
0.020
 Why?
Area Under Curve
1
2010
329
0.020
 Why?
Prognosis
2
2012
4323
0.020
 Why?
International Agencies
1
2009
30
0.020
 Why?
Cystic Fibrosis
1
1998
1173
0.020
 Why?
Erythrocytes
1
1994
751
0.020
 Why?
Chromatography, High Pressure Liquid
1
1989
581
0.020
 Why?
Mass Spectrometry
1
2010
744
0.020
 Why?
Genome, Human
1
2009
420
0.020
 Why?
Pilot Projects
1
2012
1896
0.020
 Why?
Models, Statistical
1
2010
679
0.010
 Why?
Genotype
1
2011
1853
0.010
 Why?
Amino Acids
1
1989
521
0.010
 Why?
Disease Models, Animal
1
1996
4559
0.010
 Why?
Receptors, Vascular Endothelial Growth Factor
1
2005
108
0.010
 Why?
Genomics
1
2009
834
0.010
 Why?
Epoprostenol
1
2004
132
0.010
 Why?
Bronchiolitis
1
2004
87
0.010
 Why?
Autoantibodies
1
2010
1512
0.010
 Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2005
975
0.010
 Why?
Fruit
1
2003
148
0.010
 Why?
Vegetables
1
2003
162
0.010
 Why?
Oligonucleotide Array Sequence Analysis
1
2004
751
0.010
 Why?
Pituitary Neoplasms
1
2004
190
0.010
 Why?
Respiratory Function Tests
1
2004
543
0.010
 Why?
Genetic Predisposition to Disease
1
2011
2355
0.010
 Why?
Adenoma
1
2004
218
0.010
 Why?
Regression Analysis
1
2003
1001
0.010
 Why?
Single-Blind Method
1
2001
319
0.010
 Why?
Weight Gain
1
2004
557
0.010
 Why?
Platelet Endothelial Cell Adhesion Molecule-1
1
2000
49
0.010
 Why?
Carcinoma
1
2001
224
0.010
 Why?
Bronchoscopes
1
1998
3
0.010
 Why?
RNA
1
2005
929
0.010
 Why?
Endoglin
1
1998
19
0.010
 Why?
Random Allocation
1
1998
366
0.010
 Why?
Genetic Linkage
1
1998
273
0.010
 Why?
Reference Values
1
1998
797
0.010
 Why?
Retrospective Studies
1
2015
17269
0.010
 Why?
Comorbidity
1
2001
1659
0.010
 Why?
Linear Models
1
1998
848
0.010
 Why?
Tumor Suppressor Protein p53
1
2000
536
0.010
 Why?
Analysis of Variance
1
1998
1304
0.010
 Why?
Longitudinal Studies
1
2003
2950
0.010
 Why?
Diet
1
2003
1280
0.010
 Why?
Receptors, Cell Surface
1
1998
372
0.010
 Why?
Alleles
1
1998
893
0.010
 Why?
Chromatography, Affinity
1
1994
80
0.010
 Why?
Infant, Premature
1
1998
619
0.010
 Why?
Risk Assessment
1
2004
3759
0.010
 Why?
Young Adult
1
2011
14192
0.010
 Why?
CD47 Antigen
1
1994
42
0.010
 Why?
Genes
1
1994
226
0.010
 Why?
Electrophoresis, Polyacrylamide Gel
1
1994
325
0.010
 Why?
Endothelium, Vascular
1
2000
951
0.010
 Why?
Moths
1
1994
52
0.010
 Why?
Cytoplasm
1
1994
257
0.010
 Why?
Carcinoid Tumor
1
1992
21
0.010
 Why?
Chromosome Mapping
1
1994
509
0.010
 Why?
Lymphocytes
1
1994
379
0.010
 Why?
Transfection
1
1994
925
0.010
 Why?
Adolescent
1
2011
22485
0.010
 Why?
Mice, Inbred BALB C
1
1994
1261
0.010
 Why?
Dyspnea
1
1992
250
0.010
 Why?
Binding Sites
1
1994
1313
0.010
 Why?
Fibrosis
1
1992
551
0.000
 Why?
Phenotype
1
1998
3157
0.000
 Why?
Aging
1
1998
1940
0.000
 Why?
Infant, Newborn
1
1998
6437
0.000
 Why?
Infant
1
1998
10064
0.000
 Why?
Child, Preschool
1
1998
11837
0.000
 Why?
Child
1
1998
22680
0.000
 Why?
Miller's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (325) concept(s)
_
Co-Authors Expand Description
See all (21) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)